Fabiflu
- All
- News
- Videos
-
"Ready To Face It...": Gautam Gambhir After Covid Drugs Row Reaches Court
- Friday June 4, 2021
- Delhi News | Reported by Arvind Gunasekar, Edited by Debanish Achom
BJP MP Gautam Gambhir has said his non-profit "will keep working for the people" a day after the Delhi government's drug regulator told the high court that his organisation kept massive stocks and distributed large quantities Fabiflu.
- www.ndtv.com
-
Gautam Gambhir Foundation Illegally Stocked Covid Medicine Fabiflu, High Court Told: Report
- Thursday June 3, 2021
- India News | Press Trust of India
The Gautam Gambhir Foundation has been found guilty of non-authorised stocking, procuring and distributing Fabiflu medicine to COVID-19 patients, the Delhi High Court was informed by the Delhi government's drug controller today.
- www.ndtv.com
-
"You're Wrong": Court Pulls Up Drug Controller Over Gautam Gambhir Report
- Monday May 31, 2021
- India News | Press Trust of India
The Delhi High Court Monday came down heavily on the drug controller for not properly examining how BJP MP Gautam Gambhir procured huge quantity of Fabiflu, used for treating COVID-19 patients.
- www.ndtv.com
-
Vivimed Labs Gains On Receiving Government's Approval To Make Favipiravir
- Monday May 10, 2021
- Business | Edited by Abhishek Vasudev
Favipiravir is indicated to treat mild to moderate cases of Covid-19 infection and is in short supply owing to rising Covid-19 infections in the country.
- www.ndtv.com/business
-
After Fabiflu, Gautam Gambhir Offers Oxygen Concentrators For Free In Delhi
- Saturday May 1, 2021
- India News | Reported by Sukirti Dwivedi, Edited by Shatabdi Chowdhury
Days after being criticised for his offer to distribute anti-viral drug Fabiflu, BJP MP Gautam Gambhir on Saturday said he will provide oxygen concentrators for free to those who need it in Delhi.
- www.ndtv.com
-
"My Few Fabiflu Strips Causing Shortage?": Gautam Gambhir Defends Offer
- Thursday April 22, 2021
- India News | Reported by Sukirti Dwivedi, Edited by Deepshikha Ghosh
BJP MP Gautam Gambhir today defended his offer of free anti-viral drug "Fabiflu" in his constituency in Delhi, which has been criticized by many including leaders of the Aam Aadmi Party (AAP) and Congress.
- www.ndtv.com
-
'Get Anti-Covid Fabiflu For Free': Gautam Gambhir Offer Fuels Twitter Row
- Thursday April 22, 2021
- India News | Reported by Sukirti Dwivedi, Edited by Vaibhav Tiwari
BJP MP Gautam Gambhir has informed people of his parliamentary constituency East Delhi that they can get antiviral drug 'Fabiflu' from his office for free.
- www.ndtv.com
-
Central Drug Agency Seeks Clarification From Glenmark On Its COVID-19 Drug
- Monday July 20, 2020
- India News | ANI
The Drugs Controller General of India (DCGI) has asked for a clarification from Glenmark Pharmaceuticals regarding its alleged "false claims" on the utilisation of anti-viral FabiFlu (favipiravir) on COVID-19 patients with comorbidities.
- www.ndtv.com
-
Glenmark Shares Surge Over 35% On Regulatory Approval For COVID-19 Drug
- Monday June 22, 2020
- Business | Edited by Abhishek Vasudev
Favipiravir being manufactured by Glenmark will be marketed by the name of Fabiflu and will be available in strength of 200 milligrams.
- www.ndtv.com/business
-
"Ready To Face It...": Gautam Gambhir After Covid Drugs Row Reaches Court
- Friday June 4, 2021
- Delhi News | Reported by Arvind Gunasekar, Edited by Debanish Achom
BJP MP Gautam Gambhir has said his non-profit "will keep working for the people" a day after the Delhi government's drug regulator told the high court that his organisation kept massive stocks and distributed large quantities Fabiflu.
- www.ndtv.com
-
Gautam Gambhir Foundation Illegally Stocked Covid Medicine Fabiflu, High Court Told: Report
- Thursday June 3, 2021
- India News | Press Trust of India
The Gautam Gambhir Foundation has been found guilty of non-authorised stocking, procuring and distributing Fabiflu medicine to COVID-19 patients, the Delhi High Court was informed by the Delhi government's drug controller today.
- www.ndtv.com
-
"You're Wrong": Court Pulls Up Drug Controller Over Gautam Gambhir Report
- Monday May 31, 2021
- India News | Press Trust of India
The Delhi High Court Monday came down heavily on the drug controller for not properly examining how BJP MP Gautam Gambhir procured huge quantity of Fabiflu, used for treating COVID-19 patients.
- www.ndtv.com
-
Vivimed Labs Gains On Receiving Government's Approval To Make Favipiravir
- Monday May 10, 2021
- Business | Edited by Abhishek Vasudev
Favipiravir is indicated to treat mild to moderate cases of Covid-19 infection and is in short supply owing to rising Covid-19 infections in the country.
- www.ndtv.com/business
-
After Fabiflu, Gautam Gambhir Offers Oxygen Concentrators For Free In Delhi
- Saturday May 1, 2021
- India News | Reported by Sukirti Dwivedi, Edited by Shatabdi Chowdhury
Days after being criticised for his offer to distribute anti-viral drug Fabiflu, BJP MP Gautam Gambhir on Saturday said he will provide oxygen concentrators for free to those who need it in Delhi.
- www.ndtv.com
-
"My Few Fabiflu Strips Causing Shortage?": Gautam Gambhir Defends Offer
- Thursday April 22, 2021
- India News | Reported by Sukirti Dwivedi, Edited by Deepshikha Ghosh
BJP MP Gautam Gambhir today defended his offer of free anti-viral drug "Fabiflu" in his constituency in Delhi, which has been criticized by many including leaders of the Aam Aadmi Party (AAP) and Congress.
- www.ndtv.com
-
'Get Anti-Covid Fabiflu For Free': Gautam Gambhir Offer Fuels Twitter Row
- Thursday April 22, 2021
- India News | Reported by Sukirti Dwivedi, Edited by Vaibhav Tiwari
BJP MP Gautam Gambhir has informed people of his parliamentary constituency East Delhi that they can get antiviral drug 'Fabiflu' from his office for free.
- www.ndtv.com
-
Central Drug Agency Seeks Clarification From Glenmark On Its COVID-19 Drug
- Monday July 20, 2020
- India News | ANI
The Drugs Controller General of India (DCGI) has asked for a clarification from Glenmark Pharmaceuticals regarding its alleged "false claims" on the utilisation of anti-viral FabiFlu (favipiravir) on COVID-19 patients with comorbidities.
- www.ndtv.com
-
Glenmark Shares Surge Over 35% On Regulatory Approval For COVID-19 Drug
- Monday June 22, 2020
- Business | Edited by Abhishek Vasudev
Favipiravir being manufactured by Glenmark will be marketed by the name of Fabiflu and will be available in strength of 200 milligrams.
- www.ndtv.com/business